{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:13:56Z","timestamp":1793067236129,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.rceng.2024.09.002","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T12:30:48Z","timestamp":1725366648000},"page":"598-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Anemia of inflammation and iron metabolism in chronic diseases"],"prefix":"10.1016","volume":"224","author":[{"given":"S.","family":"Conde D\u00edez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"de las Cuevas Allende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Conde Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rceng.2024.09.002_bib0005","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra1804281","article-title":"Anemia of inflammation","volume":"381","author":"Ganz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rceng.2024.09.002_bib0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"3","author":"Weiss","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.medcli.2020.07.035","article-title":"Anemia de las enfermedades cr\u00f3nicas: fisiopatolog\u00eda, diagn\u00f3stico y tratamiento","volume":"156","author":"De las Cuevas Allende","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2024.09.002_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","article-title":"Toll-like receptors in immunity and inflammatory diseases- past, present, and future","volume":"59","author":"Vijay","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0025","unstructured":"Camaschella C and Weiss G. Anemia of chronic disease\/anemia of inflammation. In: UpToDate, Means RT (Ed), UpToDate, Waltham, MA (Accessed on October 04, 2023)."},{"key":"10.1016\/j.rceng.2024.09.002_bib0030","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood.2021013472","article-title":"The role of iron in chronic inflammatory diseases: from mechanisms to treatment options in anemia of inflammation","volume":"140","author":"Marques","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3390\/metabo14040228","article-title":"Iron absorption- molecular and pathophysiological aspects","volume":"14","author":"Corenti","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.rceng.2024.09.002_bib0040","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.medcli.2016.10.047","article-title":"Estado actual del metabolismo del hierro: implicaciones cl\u00ednicas y terap\u00e9uticas","volume":"148","author":"Conde D\u00edez","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rceng.2024.09.002_bib0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood.2022016987","article-title":"Liver sinusoidal endothelial cells induce BMP6 expression in response to non\u2013transferrin-bound iron","volume":"141","author":"Charlebois","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.2022019049","article-title":"Non\u2013transferrin-bound iron takes the driver\u2019s seat","volume":"141","author":"Knutson","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","article-title":"Hepcidin and iron in health and disease","volume":"74","author":"Nemeth","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.rceng.2024.09.002_bib0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjh.17252","article-title":"Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders","volume":"193","author":"Xu","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0065","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1002\/jcp.30247","article-title":"Erythroferrone structure, function, and physiology: iron homeostasis and beyon","volume":"236","author":"Srole","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.2021014326","article-title":"Erythroferrone in iron regulation and beyond","volume":"139","author":"Babitt","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0075","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood.2023022724","article-title":"The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling","volume":"143","author":"Sardo","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0080","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2023023645","article-title":"Ironing erythroid cells takes FLG1 and ERFE to tango","volume":"143","author":"Silvestri","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0085","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.rceng.2024.09.002_bib0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1084\/jem.20170396","article-title":"Iron modulation of erythropoiesis is associated with scribble-mediated control of the erythropoietin receptor","volume":"215","author":"Khalil","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.rceng.2024.09.002_bib0095","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0100","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.3390\/nu13113732","article-title":"Physiology and inflammation driven pathophysiology of iron homeostasis - mechanistic insights into anemia of inflammation and its treatment","volume":"13","author":"Lanser","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.rceng.2024.09.002_bib0105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10654-020-00678-5","article-title":"Anemia and iron metabolism in COVID\u201019: a systematic review and meta\u2010analysis","volume":"35","author":"Taneri","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/v16040542","article-title":"Mechanisms and cardiorenal complications of chronic anemia in people with HIV","volume":"16","author":"Kamvuma","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.rceng.2024.09.002_bib0115","article-title":"Anemia, iron, and HIV: decoding the interconnected pathways: a review","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.rceng.2024.09.002_bib0120","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/MNH.0000000000000514","article-title":"Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease","volume":"28","author":"Babitt","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.rceng.2024.09.002_bib0125","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.3390\/ijms20174195","article-title":"The role of fibroblast growth factor 23 in inflammation and anemia","volume":"20","author":"Czaya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rceng.2024.09.002_bib0130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/CCM.0000000000001607","article-title":"Iron parameters determine the prognosis of critically ill patients","volume":"44","author":"Tacke","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.rceng.2024.09.002_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000497123","article-title":"Potential of parameters of iron metabolism for the diagnosis of anemia of inflammation in the critically ill","volume":"47","author":"Boshuizen","year":"2020","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.rceng.2024.09.002_bib0140","unstructured":"Drews RE. Causes of anemia in patients with c\u00e1ncer. In: UpToDate, Means RT (Ed), UpToDate, Waltham, MA (Accessed on November 03, 2023)."},{"key":"10.1016\/j.rceng.2024.09.002_bib0145","first-page":"989","article-title":"Iron metabolism in cancer and senescence: a cellular perspective","volume":"12","author":"Crescenzi","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.rceng.2024.09.002_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/1878-0261.13649","article-title":"A guide to ferroptosis in c\u00e1ncer","author":"Yapici","year":"2024","journal-title":"Mol Oncol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0155","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.7150\/ijms.46163","article-title":"The significance of iron deficiency and anemia in a real-life COPD cohort","volume":"17","author":"Pizzini","year":"2020","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.rceng.2024.09.002_bib0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11739-020-02288-1","article-title":"Anaemia, iron homeostasis and pulmonary hypertension: a review","volume":"15","author":"Sonnweber","year":"2020","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.rceng.2024.09.002_bib0165","article-title":"Anemia and heart failure: a narrative review","volume":"14","author":"Ashok","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.rceng.2024.09.002_bib0170","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ajh.24820","article-title":"Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management","volume":"92","author":"Cappellini","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0175","first-page":"1","article-title":"Pathogenesis of autoimmune disease","volume":"10","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0180","article-title":"Iron metabolism: an under investigated driver of renal pathology in lupus nephritis","volume":"8","author":"Wlazlo","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.rceng.2024.09.002_bib0185","first-page":"39","article-title":"The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease","volume":"14","author":"Wo\u017aniak","year":"2019","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0190","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.3390\/nu13114008","article-title":"Iron deficiency anemia in inflammatory bowel diseases-a narrative review","volume":"13","author":"Mahadea","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.rceng.2024.09.002_bib0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/hematology.2019000035","article-title":"New diagnostic tools for delineating iron status","volume":"2019","author":"Ginzburg","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.rceng.2024.09.002_bib0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40001-022-00922-6","article-title":"How to diagnose iron deficiency in chronic disease: a review of current methods and potential marker for the outcome","volume":"28","author":"Rohr","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.rceng.2024.09.002_bib0205","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3324\/haematol.2013.084624","article-title":"Manipulation of the hepcidin pathway for therapeutic purposes","volume":"98","author":"Fung","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.rceng.2024.09.002_bib0210","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1111\/bph.13188","article-title":"Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats","volume":"172","author":"Barrett","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0215","article-title":"Hepcidin: a promising therapeutic target for iron disorders. A systematic review","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rceng.2024.09.002_bib0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/ph11040127","article-title":"Hepcidin therapeutics","volume":"11","author":"Katsarou","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.rceng.2024.09.002_bib0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/ijms19020389","article-title":"Hypoxia-inducible factor and its role in the management of anemia in chronic kidney disease","volume":"19","author":"Kaplan","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.rceng.2024.09.002_bib0230","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.3390\/jcm12134217","article-title":"Iron parameters in patients treated with roxadustat for anemia of chronic kidney disease","volume":"12","author":"Ganz","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.rceng.2024.09.002_bib0235","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.18632\/aging.204611","article-title":"A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease","volume":"15","author":"Chen","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.rceng.2024.09.002_bib0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/ph12040170","article-title":"Therapeutic advances in regulating the hepcidin\/ferroportin axis","volume":"12","author":"Hawula","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.rceng.2024.09.002_bib0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MOH.0000000000000236","article-title":"Hepcidin regulation in the anemia of inflammation","volume":"23","author":"Wang","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0250","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.3324\/haematol.2015.140772","article-title":"Anti-hemojuvelin antibody corrects anemia caused by inappropriately high hepcidin levels","volume":"101","author":"Kovac","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.rceng.2024.09.002_bib0255","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1208\/s12248-015-9770-4","article-title":"Anti-repulsive guidance molecule C (RGMc) antibodies increases serum iron in rats and cynomolgus monkeys by hepcidin downregulation","volume":"17","author":"B\u00f6ser","year":"2015","journal-title":"AAPS J"},{"key":"10.1016\/j.rceng.2024.09.002_bib0260","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2018-06-857995","article-title":"Erythroferrone inhibits the induction of hepcidin by BMP6","volume":"132","author":"Arezes","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105452","article-title":"Characterization of erythroferrone oligomerization and its impact on BMP antagonism","volume":"300","author":"Mast","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rceng.2024.09.002_bib0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4078\/jrd.2016.23.1.37","article-title":"Clinical and hematological effects of tocilizumab on serum hepcidin, anemia response and disease activity in patients with active rheumatoid arthritis","volume":"23","author":"Park","year":"2016","journal-title":"J Rheum Dis"},{"key":"10.1016\/j.rceng.2024.09.002_bib0275","article-title":"Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: a case report and literature review","volume":"25","author":"Sun","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rceng.2024.09.002_bib0280","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1182\/bloodadvances.2023010745","article-title":"Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes","volume":"7","author":"Pierson","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.rceng.2024.09.002_bib0285","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0394632017714695","article-title":"Anti-TNF-\u03b1 effects on anemia in rheumatoid and psoriatic arthritis","volume":"30","author":"Corrado","year":"2017","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0290","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/blood-2013-06-505792","article-title":"A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates","volume":"122","author":"Cooke","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13045-017-0427-x","article-title":"A first-inhuman phase 1 study of a hepcidin monoclonal antibody LY2787106, in cancer-associated anemia","volume":"10","author":"Vadhan-Raj","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212023","article-title":"First-inhuman Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis","volume":"14","author":"Renders","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rceng.2024.09.002_bib0305","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood-2012-09-456756","article-title":"The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys","volume":"121","author":"Schwoebel","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rceng.2024.09.002_bib0310","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/bph.13433","article-title":"Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects","volume":"173","author":"Boyce","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0315","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/bcp.13877","article-title":"Targeting the hepcidin\u2013ferroportin pathway in anaemia of chronic kidney disease","volume":"85","author":"Sheetz","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rceng.2024.09.002_bib0320","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/mol.112.083428","article-title":"High-throughput screening of small molecules identifies hepcidin antagonists","volume":"83","author":"Fung","year":"2013","journal-title":"Mol Pharmacol"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:26:34Z","timestamp":1731543994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887424001164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2254887424001164"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2024.09.002","relation":{},"ISSN":["2254-8874"],"issn-type":[{"value":"2254-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anemia of inflammation and iron metabolism in chronic diseases","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2024.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2024.06.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}